Moffett Brady S, Orellana Renán
Texas Children's Hospital, Department of Pharmacy, Houston, TX, USA.
Pediatr Crit Care Med. 2006 Nov;7(6):600-2. doi: 10.1097/01.PCC.0000244406.98058.9A.
We describe the use of fenoldopam to increase urine output in a pediatric patient with sepsis, heart failure, oliguria, and volume overload.
Case report.
A tertiary pediatric intensive care unit.
A 17-year-old male who was being treated for acute lymphoblastic leukemia and was admitted from outside the hospital to the pediatric intensive care unit, in septic shock, after a course of chemotherapy.
A continuous fenoldopam infusion of 0.03 microg/kg/min was added to a regimen of multiple inotropic and vasopressor agents and a furosemide continuous infusion.
Urine output increased 586% 12 hrs after starting the fenoldopam infusion and 775% from baseline 24 hrs after starting the infusion. Diuretics were decreased while maintaining adequate urine output. No hypotension was noted.
Fenoldopam increased urine output in a pediatric patient who was in septic shock and oliguria. The mechanism for this effect is unclear, and further trials are necessary to determine the role of fenoldopam in this patient population.
我们描述了使用非诺多泮增加一名患有脓毒症、心力衰竭、少尿和容量超负荷的儿科患者尿量的情况。
病例报告。
一家三级儿科重症监护病房。
一名17岁男性,正在接受急性淋巴细胞白血病治疗,在接受一个疗程化疗后,从院外转入儿科重症监护病房,处于感染性休克状态。
在多种正性肌力药和血管加压药以及持续静脉输注呋塞米的治疗方案中,加入非诺多泮,以0.03微克/千克/分钟的速度持续静脉输注。
开始输注非诺多泮12小时后尿量增加了586%,开始输注24小时后尿量较基线增加了775%。在维持充足尿量的同时减少了利尿剂的使用。未观察到低血压。
非诺多泮增加了一名处于感染性休克和少尿状态的儿科患者的尿量。这种作用的机制尚不清楚,需要进一步试验以确定非诺多泮在该患者群体中的作用。